Arcutis Biotherapeutics

ARQTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.492 B

$27.78 +7.01%

Close of 22 Sept 2026

Revenue

$376.1M

#2046 by revenue

Earnings

-$16.1M

Loss-making

Shares outstanding

125,691,961

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#71Organon & Co.OGN$3.60B
#72Enliven TherapeuticsELVN$3.53B
#73Arcutis BiotherapeuticsARQT$3.49B
#74Arcus BiosciencesRCUS$3.42B
#75Dyne TherapeuticsDYN$3.20B

What if Arcutis Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$240,540.20

Per share 8,659× higher

Bitcoin $1.74T

$13,856.53

Per share 499× higher

Nvidia $5.52T

$43,883.21

Per share 1,580× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Arcutis Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.